Immunophenotypic analysis of T-cell subpopulations
Diagnosis . | Age at diagnosis, y . | Sex . | α-β TCR (0%-1.5%)† . | γ-δ TCR (0%-2%) . | CD4−/CD8− (0%-4%) . |
---|---|---|---|---|---|
MAA | 15 | F | 2.3 | 4.5 | 7 |
MAA | 16 | F | 1.1 | 6.4 | 7 |
SAA | 4 | M | 2.2 | 1.6 | 4.6 |
SAA | 11 | F | 1 | 4.8 | 3.8 |
SAA | 10 | M | 1.6 | 2.5 | 3.7 |
SAA | 10 | M | 2.2 | 4.2 | 5.5 |
SAA | 3 | F | 2.7 | 4.6 | 7.3 |
SAA | 15 | F | 0.8 | 5.1 | 6.6 |
SAA | 14 | M | 1.5 | 5.2 | 6.7 |
SAA | 12 | M | 1.1 | 8 | 9.1 |
SAA* | 16 | F | 1.3 | 3 | 4.3 |
Diagnosis . | Age at diagnosis, y . | Sex . | α-β TCR (0%-1.5%)† . | γ-δ TCR (0%-2%) . | CD4−/CD8− (0%-4%) . |
---|---|---|---|---|---|
MAA | 15 | F | 2.3 | 4.5 | 7 |
MAA | 16 | F | 1.1 | 6.4 | 7 |
SAA | 4 | M | 2.2 | 1.6 | 4.6 |
SAA | 11 | F | 1 | 4.8 | 3.8 |
SAA | 10 | M | 1.6 | 2.5 | 3.7 |
SAA | 10 | M | 2.2 | 4.2 | 5.5 |
SAA | 3 | F | 2.7 | 4.6 | 7.3 |
SAA | 15 | F | 0.8 | 5.1 | 6.6 |
SAA | 14 | M | 1.5 | 5.2 | 6.7 |
SAA | 12 | M | 1.1 | 8 | 9.1 |
SAA* | 16 | F | 1.3 | 3 | 4.3 |